English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: The aim of the present study was to determine the Rabex-5 level in the plasma of patients who were found to have benign and malignant cytology as a result of fine-needle aspiration biopsy implemented on thyroid nodules and to determine whether there was a difference between benign and malignant. Method: The cytology of 117 benign and 26 malignant thyroid nodules was evaluated as the study material. Results: It was determined that the nodule diameter had no effect on benign and malignant cytology (p 0.998). There was no significant difference found between age and benign and malignant cytology results (p 0.591). There was no difference between female and male genders in terms of Rabex-5 level (p 0.654). Conclusions: In conclusion, it was found that there was no difference in plasma RABEX-5 levels of patients with benign and malignant thyroid nodule cytology. However, it is thought that further studies to evaluate the expression of Rabex-5 in cancerous tissues of patients with thyroid malignancies will provide a scientific contribution

Assessment of rabex-5 level of thyroid nodules with benign and malignant characteristics in aspiration cytology